Regeneron/Sanofi to cut price of heart drug in Express Scripts deal

Regeneron/Sanofi to cut price of heart drug in Express Scripts deal


Regeneron Pharmaceuticals Inc and Sanofi SA will cut the net price of their expensive cholesterol drug for Express Scripts Holdings Co customers in exchange for greater patient access, with some savings to be shared with consumers, the companies said on Tuesday. FILE PHOTO: French multinational pharmaceutical company SANOFI logo is seen at the headquarters in Paris, France, March 8, 2016.



from Biotech News